Patents Examined by Jane Williams
  • Patent number: 5328833
    Abstract: Pathogenic microorganisms such as Staphylococcus aureus are differentiated and identified by observing the selective inhibition of the microorganism which occurs when it is contacted with Alphazurine A dye.
    Type: Grant
    Filed: April 4, 1991
    Date of Patent: July 12, 1994
    Inventors: William W. Ayres, John Duda
  • Patent number: 5328822
    Abstract: An apparatus and process for accurately determining settling data for the settling of erythrocyte cells from a plasma fluid in a test specimen of blood. The apparatus includes a settling tube, a sensing assembly movably mounted proximate the settling tube. Preferably an infrared emitter and detector are provided in the sensing assembly, and a control assembly is provided which senses data at a high rate and is responsive to the sensed data to sample or store the time at which sensed reflectivity exceeds a threshold level. When the threshold is reached, data is sampled and the tracking head is moved by a very small step. This process is repeated to enable tracking of the descent of the separation boundary between the erythrocyte cells and plasma fluid. The apparatus senses changes in reflectivity of the erythrocyte portion of the specimen below and up to the separation boundary.
    Type: Grant
    Filed: April 23, 1990
    Date of Patent: July 12, 1994
    Assignee: Solid State Farms, Inc.
    Inventors: David K. McKinney, Milton E. Fuller, Berry V. Carone
  • Patent number: 5326706
    Abstract: A homeostatic organ preservation system includes structure for defining a chamber for holding a donor organ, and a pump for providing a perfusion solution to the organ. A first conduit is coupled to the pump and is adapted to be coupled to the organ. The first conduit provides perfusion solution from the pump to the organ. A second conduit is coupled to the pump and to the organ chamber. The second conduit returns perfusion solution from the organ chamber to the pump. A pressure sensor is coupled to the first conduit to sense the pressure of the perfusion solution in the first conduit. The pressure sensor provides an output signal which is indicative of the vascular resistance of the organ. A pump control circuit is also included. The pump control circuit is responsive to the output signal of the pressure sensor to raise and lower the pump pulse rate respectively in response to a decrease and increase in the organ vascular resistance.
    Type: Grant
    Filed: August 31, 1990
    Date of Patent: July 5, 1994
    Assignee: Research Foundation of State University of New York
    Inventors: Marc J. Yland, David Anaise
  • Patent number: 5324661
    Abstract: A method for identifying soil microbial strains which may be bacterial degraders of pollutants comprising the steps of placing a concentration of a pollutant in a substantially closed container, placing the container in a sample of soil for a period of time ranging from one minute to several hours, retrieving the container, collecting the contents of the container, and microscopically determining the identity of the bacteria present. Different concentrations of the pollutant can be used to determine which bacteria respond to each concentration. The method can be used for characterizing a polluted site or for looking for naturally occurring biological degraders of the pollutant. Then bacteria identified as degraders of the pollutant and as chemotactically attracted to the pollutant are used to inoculate contaminated soil.
    Type: Grant
    Filed: March 4, 1991
    Date of Patent: June 28, 1994
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventor: Terry C. Hazen
  • Patent number: 5316918
    Abstract: An apparatus and method for determining the sensitivity of MAI to different antimicrobial agents and dosages thereof is provided. The apparatus comprises a plurality of test tubes adapted to contain an amount of an antimicrobial agent to be tested and MAI complex organisms to be assayed and a separate paraffin coated slide adapted for placement in each of the test tubes. The growth of the MAI complex organisms on the slide can be used to determine the concentration of the antimicrobial agent necessary to resist MAI complex organism growth on the slide. An associated method is also disclosed.
    Type: Grant
    Filed: February 25, 1992
    Date of Patent: May 31, 1994
    Assignee: Infectech, Inc.
    Inventor: Robert A. Ollar
  • Patent number: 5308757
    Abstract: In determining the effectiveness of parameters on cells, after treatment of the cells with one or more selected parameters, the results of the treatment can be quickly determined by measuring the number n.sub.0 of cells having a predetermined cell form, subsequently mechanically stressing the cells for a sufficient period of time t to change the cell form substantially, thereafter again measuring the number n of cells having the predetermined cell form, and determining the cell viability .tau.defined by .tau.=t/1n(n.sub.0 /n).
    Type: Grant
    Filed: August 8, 1991
    Date of Patent: May 3, 1994
    Assignees: Hitachi, Ltd., Hitachi Koki Co., Ltd.
    Inventors: Yoshio Kawamura, Yoshu Yoshiba, Shinji Tanaka, Kazuo Sato, Jiro Kikuchi, Kahoru Takahashi
  • Patent number: 5302524
    Abstract: A method of stimulating seedling growth which comprises applying a coal-derived oxidation product to the medium in which the seedling is growing. The product is in the form of a solution or a slurry having a pH in the range of 2 to 12 and has the following elemental and functional group analysis (on an air-dried basis):______________________________________ ELEMENTAL ANALYSIS Element Range (%) ______________________________________ Carbon 30-70 Hydrogen 2-6 Nitrogen 0.1-5 Sulphur 0.1-10 Oxygen 15-45 ______________________________________ FUNCTIONAL GROUP ANALYSIS Functional Group Range (meq/g) ______________________________________ Total acidity 3-13 Carboxylic groups 0.5-12 Phenolic groups 0.
    Type: Grant
    Filed: May 14, 1990
    Date of Patent: April 12, 1994
    Assignee: National Energy Council
    Inventors: Hendrik A. Van De Venter, Johannes Dekker, Izak J. Cronje
  • Patent number: 5292644
    Abstract: A rapid process for detecting pathogenic microorganisms in products for human consumption comprises contacting the microorganisms with a methylumbelliferone substrate. The substrate is hydrolyzed into methylumbelliferone by an enzyme given off by the microorganisms. Hydrolysis is accelerated by sodium lauryl sulfate, which renders the microorganisms more permeable to the substrate, the enzyme, or both. The methylumbelliferone is detected by its fluorescence, either in solution or on an agar medium supporting microcolonies formed from individual microorganisms.
    Type: Grant
    Filed: February 8, 1991
    Date of Patent: March 8, 1994
    Inventor: James D. Berg
  • Patent number: 5290695
    Abstract: Disclosed are novel enzymes, heparitinase T-I, heparitinase T-II, heparitinase T-III and heparitinase T-IV, which degrade heparan sulfate and/or heparin, a process for producing thereof by cultivating a novel Bacillus circulans HpT 298 having an ability of producing these enzymes and a novel Bacillus circulans HpT 298.
    Type: Grant
    Filed: February 28, 1992
    Date of Patent: March 1, 1994
    Assignee: Seikagaku Kogyo Kabushiki Kaisha
    Inventors: Kiyoshi Morikawa, Hirofumi Miyazono, Hiroshi Maruyama, Keiichi Yoshida
  • Patent number: 5290701
    Abstract: The presence and a quantitative estimate of microorganisms in a sample is determined by monitoring the growth of vertical subsurface colonies in a soft agar medium. A culture cell containing the sample-agar mixture is positioned on a rotating circular index table and, at an inspection station, a video camera monitors colony growth with an image processor and computer processing the output of the video camera. Select output parameters include, but are not restricted to, colony counts and growth rates, morphological variations and identification criteria.
    Type: Grant
    Filed: August 28, 1991
    Date of Patent: March 1, 1994
    Inventor: Judd R. Wilkins
  • Patent number: 5288631
    Abstract: A tubular membrane suitable for the delivery of a gaseous fluid to a surrounding medium has an irregular exterior surface to facilitate the diffusion of gas from the lumen to the exterior.
    Type: Grant
    Filed: January 17, 1992
    Date of Patent: February 22, 1994
    Assignee: Centocor Incorporated
    Inventors: Mark F. Baumgartner, William R. Tolbert, John Shanahan
  • Patent number: 5270172
    Abstract: A method is disclosed for predicting response of a tumor patient to therapy, and selecting appropriate therapy for malignant neoplasms such as breast, ovarian and gastrointestinal cancer. A sample of tumor cells is cultured in the presence of 10 .mu.g/ml estradiol, and inhibition of cell growth in the culture paradoxically indicates an estrogen dependent tumor that will respond to antiestrogenic therapy. Another sample of tumor cells is cultured in the presence of a chemotherapeutic agent which predicts response of the tumor to in vivo administration of a cytotoxic agent. The chemotherapeutic agent is preferably a cytotoxic drug, or a drug having both cytotoxic and antiestrogenic mechanisms of action. A particularly suitable substance having both mechanisms of action is: ##STR1## wherein R.sup.1 H, OH, OOC(CH.sub.2).sub.2 CO.sub.2 H or CH.sub.3 COO; R.sup.2 is C.sub.6 H.sub.4 OH, C.sub.6 H.sub.4 OCOCH.sub.3, C.sub.6 H.sub.4 OOC(CH.sub.2)CO.sub.2 H, or C.sub.6 H.sub.5 ; and X is C.sub.6 H.sub.3 -2,4(NO.sub.2).
    Type: Grant
    Filed: April 26, 1991
    Date of Patent: December 14, 1993
    Assignee: Dekk-Tek, Inc.
    Inventor: Lee R. Morgan
  • Patent number: 5266480
    Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells and tissues in vitro for prolonged periods of time. In accordance with the invention, cells derived from a desired tissue are inoculated and grown on a pre-established stromal support matrix. The stromal support matrix comprises stromal cells, such as fibroblasts actively growing on a three-dimensional matrix. Stromal cells may also include other cells found in loose connective tissue such as endothelial cells, macrophages/monocytes, adipocytes, pericytes, reticular cells found in bone marrow stroma, etc. The stromal matrix provides the support, growth factors, and regulatory factors necessary to sustain long-term active proliferation of cells in culture. When grown in this three-dimensional system, the proliferating cells mature and segregate properly to form components of adult tissues analogous to counterparts found in vivo.
    Type: Grant
    Filed: August 30, 1990
    Date of Patent: November 30, 1993
    Assignee: Advanced Tissue Sciences, Inc.
    Inventors: Gail K. Naughton, Brian A. Naughton
  • Patent number: 5229288
    Abstract: A cytotoxicity test method is provided which measures the effect of test substances or physical stimulation on cells. The method is both simple and sensitive and is useful for a wide variety of substances and stimulations.
    Type: Grant
    Filed: April 23, 1991
    Date of Patent: July 20, 1993
    Assignee: W. R. Grace & Co.-Conn.
    Inventors: Yuichi Mori, Toshiaki Takezawa, Manabu Yamazaki
  • Patent number: 5229271
    Abstract: A method of testing a substance for its ability to promote, maintain, increase or arrest hair growth, or influence hair pigmentation comprise the steps of:i. isolating a viable hair follicle from skin, without damaging the hair bulb;ii. maintaining the isolated, viable hair follicle in a nutrient medium;iii. contacting the isolated hair follicle in said medium with a test substance, andiv. assessing the response of the hair follicle to said test substance.
    Type: Grant
    Filed: December 13, 1990
    Date of Patent: July 20, 1993
    Assignee: Chesebrough-Pond's USA Co., Division of Conopco, Inc.
    Inventor: Michael Philpott
  • Patent number: 5217716
    Abstract: This invention provides methods and an apparatus for peroxidizing lipoproteins and introducing them into a person infected with a virus such as HIV to help that person fight the disease. Peroxidized low density lipoproteins are shown to preferentially kill HIV-infected cells as well as the HIV virus.
    Type: Grant
    Filed: October 15, 1991
    Date of Patent: June 8, 1993
    Assignee: The Beth Israel Hospital Association
    Inventors: Eric T. Fossel, James E. Lyddy
  • Patent number: 5217875
    Abstract: A method for detecting biological activities in a specimen, for instance a blood sample, employing a sealable container with a culture medium, into which the sample is introduced, wherein metabolic processes are enhanced in the presence of microorganisms in the sample, thereby causing changes to take place in the concentrations of the substances subject to such processes. The concentration changes are measured by optodes that are in direct contact with the sample, and by an excitation and detection assembly assigned to these optodes, to which is connected an evaluation unit for determining concentration changes of the substances over time.
    Type: Grant
    Filed: March 29, 1990
    Date of Patent: June 8, 1993
    Assignee: AVL AG
    Inventors: Hellfried Karpf, Herbert Smole
  • Patent number: 5213971
    Abstract: A process for inducing cytochrome P-450 enzyme production in bacteria of the genus Streptomyces using inducers such as soybean flour, genistein or genistin is described. Uses for the cytochrome P-450 enzymes produced are also discussed as is a process for using genetically engineered Streptomyces to determine the mutagenicity of chemicals.
    Type: Grant
    Filed: August 28, 1991
    Date of Patent: May 25, 1993
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Daniel A. Kunz, Fateme S. Sariaslani
  • Patent number: 5210022
    Abstract: A chromogenic .beta.-galactosidase substrate producing an insoluble precipitate of a first color when reacted upon by .beta.-galactosidase and a chromogenic .beta.-glucuronidase substrate producing an insoluble precipitate of a second, contrasting color when reacted upon by .beta.-glucuronidase are combined in a test medium for quantitatively identifying and differentiating general coliforms and E. coli. The .beta.-galactosidase substrate 5-bromo-4-chloro-3-indolyl-.beta.-D-galactopyranoside which produces an indigo blue precipitate when reacted upon by .beta.-galactosidase may be used with one of the novel compounds 6-chloroindolyl-.beta.-D-glucuronide, 4,6-dichloroindolyl-.beta.-D-glucuronide, 6,7-dichloroindolyl-.beta.-D-glucuronide, and 4,6,7-trichloroindolyl-.beta.-D-glucuronide, which produce mauve or magenta precipitates when reacted upon by .beta.-glucuronidase. The .beta.-glucuronidase substrate 5-bromo-4-chloro-3-indolyl-.beta.
    Type: Grant
    Filed: April 20, 1990
    Date of Patent: May 11, 1993
    Assignee: RCR Scientific, Inc.
    Inventors: Jonathan N. Roth, Wilfred J. Ferguson
  • Patent number: 5206151
    Abstract: A rapid method for determining the minimum inhibitory concentration of biocides or biocidal agents for use in various microbiological contaminated aqueous systems is disclosed. This rapid technique provides for an opportunity to determine the minimum amount of anti-microbial agents, or biocides either singularly or combination, to control microbiological growth in aqueous streams contaminated by microorganisms. The test involves the use of reduction oxidation indicator dye systems which react to enhanced microbiological activity producing reducing enzymes such as dehydrogenase enzymes. The technique provides an answer within a time period of from about 30 minutes to about 8-10 hours as opposed to normal testing procedure that can require up to 1-2 weeks.
    Type: Grant
    Filed: June 11, 1990
    Date of Patent: April 27, 1993
    Assignee: Nalco Chemical Company
    Inventor: Linda R. Robertson